Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer-Reference-Cited by-同舟云学术

Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer

Published:2018-08 Issue:2 Volume:128 Page:301-307
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Strouthos Iosif,Chatzikonstantinou Georgios,Zamboglou Nikolaos,Milickovic Natasa,Papaioannou Sokratis,Bon Dimitra,Zamboglou Constantinos,Rödel Claus,Baltas Dimos,Tselis Nikolaos

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference48 articles.

1. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

2. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer. Long-term results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2014

3. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95–09;Zietman;J Clin Oncol,2010

4. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate;Sathya;J Clin Oncol,2005

5. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer;Hoskin;Radiother Oncol,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical failure and toxicity in treatment with brachytherapy and external beam radiotherapy compared with radical prostatectomy in localized prostate cancer;Reports of Practical Oncology and Radiotherapy;2022-07-06

2. High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort;Clinical and Translational Radiation Oncology;2022-07

3. Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer;Acta Oncologica;2022-04-29

4. Could high-dose-rate monotherapy survive beyond stereotactic ablative radiotherapy era for clinically localized prostate cancer?;Radiotherapy and Oncology;2022-02

5. Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis;Frontiers in Oncology;2021-11-26